What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Polly A. Newcomb mainly focuses on Internal medicine, Colorectal cancer, Oncology, Odds ratio and Cancer.
Her Internal medicine research integrates issues from Gastroenterology and Gynecology.
The various areas that she examines in her Colorectal cancer study include Genome-wide association study, Bioinformatics and Pathology.
The Oncology study which covers Microsatellite instability that intersects with KRAS and Immunohistochemistry.
Polly A. Newcomb has researched Odds ratio in several fields, including Mendelian randomization, Absolute risk reduction, Confidence interval, Predictive value of tests and Family history.
Her studies deal with areas such as Young adult, Rectum and Incidence as well as Cancer.
Her most cited work include:
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (4695 citations)
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker (1117 citations)
- Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 (677 citations)
What are the main themes of her work throughout her whole career to date?
Polly A. Newcomb mainly investigates Internal medicine, Colorectal cancer, Oncology, Cancer and Odds ratio.
Her is doing research in Hazard ratio, Breast cancer, Case-control study, Epidemiology and Proportional hazards model, both of which are found in Internal medicine.
Her Colorectal cancer research is multidisciplinary, incorporating elements of Body mass index, Genome-wide association study, Single-nucleotide polymorphism, Bioinformatics and Microsatellite instability.
The Oncology study combines topics in areas such as Surgery, Lynch syndrome, Genotype, Endometrial cancer and Cohort.
Her research investigates the connection between Cancer and topics such as Family history that intersect with problems in Relative risk.
Her study in Odds ratio is interdisciplinary in nature, drawing from both Mendelian randomization, Logistic regression, Gastroenterology, Confidence interval and Colonoscopy.
She most often published in these fields:
- Internal medicine (91.92%)
- Colorectal cancer (83.83%)
- Oncology (71.71%)
What were the highlights of her more recent work (between 2019-2021)?
- Colorectal cancer (83.83%)
- Internal medicine (91.92%)
- Oncology (71.71%)
In recent papers she was focusing on the following fields of study:
Colorectal cancer, Internal medicine, Oncology, Cancer and Odds ratio are her primary areas of study.
Her Colorectal cancer research includes elements of Mendelian randomization, Genome-wide association study, Single-nucleotide polymorphism, Cancer research and Microsatellite instability.
Her study looks at the relationship between Internal medicine and topics such as Gastroenterology, which overlap with European Prospective Investigation into Cancer and Nutrition and Prospective cohort study.
Polly A. Newcomb has included themes like Body mass index, Lynch syndrome, KRAS, Proportional hazards model and Breast cancer in her Oncology study.
Her Cancer study integrates concerns from other disciplines, such as Lower risk, Penetrance and Family history.
Polly A. Newcomb combines subjects such as CpG Island Methylator Phenotype and Logistic regression with her study of Odds ratio.
Between 2019 and 2021, her most popular works were:
- Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (138 citations)
- A Population-Based Study of Genes Previously Implicated in Breast Cancer (61 citations)
- Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. (38 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Her main research concerns Internal medicine, Colorectal cancer, Oncology, Cancer and Case-control study.
Her biological study spans a wide range of topics, including Epigenomics and Epigenetics.
Polly A. Newcomb interconnects Single-nucleotide polymorphism, Medical genetics, Microsatellite instability and Hazard ratio in the investigation of issues within Colorectal cancer.
Her Oncology research incorporates themes from Breast cancer, Genome-wide association study, Epidemiology and Family history.
Her work on Lynch syndrome and Carcinogenesis as part of general Cancer research is frequently linked to Identification and Extramural, bridging the gap between disciplines.
She works mostly in the field of Case-control study, limiting it down to topics relating to Mendelian randomization and, in certain cases, Gastroenterology, Prospective cohort study, European Prospective Investigation into Cancer and Nutrition and Bilirubin, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
